(Q39612049)

13 September 2017

CD103 is a hallmark of tumor-infiltrating regulatory T cells (English)

1 reference

13 September 2017

6

0 references

Stefan Endres

11

object named as

Stefan Endres

1 reference

13 September 2017

David Anz

1

1 reference

13 September 2017

Wolfgang Mueller

2

1 reference

13 September 2017

Michaela Golic

3

1 reference

13 September 2017

Wolfgang G Kunz

4

1 reference

13 September 2017

Moritz Rapp

5

1 reference

13 September 2017

Jonathan Ellermeier

7

1 reference

13 September 2017

Joachim W Ellwart

8

1 reference

13 September 2017

Max Schnurr

9

1 reference

13 September 2017

Carole Bourquin

10

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 April 2011

1 reference

International Journal of Cancer

13 September 2017

1 reference

13 September 2017

129

1 reference

13 September 2017

10

1 reference

13 September 2017

2417-2426

1 reference

How do CD4+CD25+ regulatory T cells control autoimmunity?

13 September 2017

1 reference

Regulating the immune response to tumours

21 January 2018

1 reference

Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy

21 January 2018

1 reference

Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors

21 January 2018

1 reference

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

21 January 2018

1 reference

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

21 January 2018

1 reference

The three Es of cancer immunoediting

21 January 2018

1 reference

Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

CD103 expression is required for destruction of pancreatic islet allografts by CD8(+) T cells

21 January 2018

1 reference

A new surface antigen on intraepithelial lymphocytes in the intestine

21 January 2018

1 reference

Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin

21 January 2018

1 reference

Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells

21 January 2018

1 reference

Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells.

21 January 2018

1 reference

Rational siRNA design for RNA interference

21 January 2018

1 reference

Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells

21 January 2018

1 reference

Recognition of E-cadherin on epithelial cells by the mucosal T cell integrin alpha M290 beta 7 (alpha E beta 7).

21 January 2018

1 reference

Role of the alphaI domain in ligand binding by integrin alphaEbeta7.

21 January 2018

1 reference

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

21 January 2018

1 reference

A Phase II trial of Denileukin Diftitox in patients with previously treated advanced non-small cell lung cancer.

21 January 2018

1 reference

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies

21 January 2018

1 reference

Studies on transcriptional regulation of the mucosal T-cell integrin alphaEbeta7 (CD103)

21 January 2018

1 reference

Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-{beta}.

21 January 2018

1 reference

CTLA-4 blockade: autoimmunity as treatment

21 January 2018

1 reference

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25902

1 reference

13 September 2017

1 reference